-Michael J Otto Researcher Activity Profile

Research Author Detailed Information 

Michael J Otto Publication Rate By Year

Michael J Otto has published 2 paper(s) in 2006, 2 paper(s) in 2008, for a total of 4 research publications in total.

Michael J Mj Otto Author Information

LAST NAME: otto

FIRST NAME: Michael J

INITIALS: mj

AFFILIATION:

Papers

Michael J Otto's Publication Record

1. Inhibition of hepatitis C replicon RNA synthesis by beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine: a specific inhibitor of hepatitis C virus replication. Year Published: 2006
Pharmasset Inc, Princeton, NJ, USA.
2. Synthesis and biological activity of 5',9-anhydro-3-purine-isonucleosides as potential anti-hepatitis C virus agents. Year Published: 2006
Pharmasset, Inc., Princeton, New Jersey 08540, USA. kwon.chun@pharmasset.com
3. The Mechanism of Action of {beta}-D-2'-Deoxy-2'-Fluoro-2'-C-Methylcytidine Involves a Second Metabolic Pathway Leading to {beta}-D-2'-Deoxy-2'-Fluoro-2'-C-Methyluridine 5'-Triphosphate, a Potent Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase. Year Published: 2008
Pharmasset, Inc., 303 A College Road East, Princeton, NJ 08540. phillip.furman@pharmasset.com.
4. The mechanism of action of beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine involves a second metabolic pathway leading to beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine 5'-triphosphate, a potent inhibitor of the hepatitis C virus RNA-dependent RNA polymerase. Year Published: 2008
Pharmasset, Inc., 303 A College Road East, Princeton, NJ 08540, USA.